309 related articles for article (PubMed ID: 25412727)
1. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12.
Hinz A; Mehnert A; Ernst J; Herschbach P; Schulte T
Support Care Cancer; 2015 Jun; 23(6):1579-87. PubMed ID: 25412727
[TBL] [Abstract][Full Text] [Related]
2. Psychometric properties of the Fear of Progression Questionnaire for parents of children with cancer (FoP-Q-SF/PR).
Clever K; Schepper F; Pletschko T; Herschbach P; Christiansen H; Martini J
J Psychosom Res; 2018 Apr; 107():7-13. PubMed ID: 29502766
[TBL] [Abstract][Full Text] [Related]
3. [Fear of progression in parents of children with cancer: adaptation of the Fear of Progression Questionnaire and correlates].
Schepper F; Abel K; Herschbach P; Christiansen H; Mehnert A; Martini J
Klin Padiatr; 2015 May; 227(3):151-6. PubMed ID: 25811743
[TBL] [Abstract][Full Text] [Related]
4. Fear of disease progression questionnaire for parents: Psychometric properties based on a sample of caregivers of children and adolescents with cystic fibrosis.
Fidika A; Herle M; Herschbach P; Goldbeck L
J Psychosom Res; 2015 Jul; 79(1):49-54. PubMed ID: 25799454
[TBL] [Abstract][Full Text] [Related]
5. Increased fear of progression in cancer patients with recurrence.
Shim EJ; Shin YW; Oh DY; Hahm BJ
Gen Hosp Psychiatry; 2010; 32(2):169-75. PubMed ID: 20302991
[TBL] [Abstract][Full Text] [Related]
6. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire.
Herschbach P; Berg P; Dankert A; Duran G; Engst-Hastreiter U; Waadt S; Keller M; Ukat R; Henrich G
J Psychosom Res; 2005 Jun; 58(6):505-11. PubMed ID: 16125517
[TBL] [Abstract][Full Text] [Related]
7. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
8. Fear of progression in partners of chronically ill patients.
Zimmermann T; Herschbach P; Wessarges M; Heinrichs N
Behav Med; 2011 Jul; 37(3):95-104. PubMed ID: 21895427
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two group therapies to reduce fear of progression in cancer patients.
Herschbach P; Book K; Dinkel A; Berg P; Waadt S; Duran G; Engst-Hastreiter U; Henrich G
Support Care Cancer; 2010 Apr; 18(4):471-9. PubMed ID: 19865833
[TBL] [Abstract][Full Text] [Related]
10. [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)].
Mehnert A; Herschbach P; Berg P; Henrich G; Koch U
Z Psychosom Med Psychother; 2006; 52(3):274-88. PubMed ID: 17156600
[TBL] [Abstract][Full Text] [Related]
11. Validity of the Fear of Progression Questionnaire-Short Form in patients with systemic sclerosis.
Kwakkenbos L; van den Hoogen FH; Custers J; Prins J; Vonk MC; van Lankveld WG; Becker ES; van den Ende CH
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):930-4. PubMed ID: 22262505
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Portuguese Version of the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) in Portuguese Cancer Survivors.
Silva S; Bártolo A; Santos IM; Paiva D; Monteiro S
Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36553990
[TBL] [Abstract][Full Text] [Related]
13. Rapid screener for the assessment of fear of progression in cancer survivors: The Fear of progression-Questionnaire Rapid Screener.
Youssef Y; Mehnert-Theuerkauf A; Götze H; Friedrich M; Esser P
Eur J Cancer Care (Engl); 2021 May; 30(3):e13400. PubMed ID: 33459435
[TBL] [Abstract][Full Text] [Related]
14. Fear of cancer progression in patients with stage IA malignant melanoma.
Wagner T; Augustin M; Blome C; Forschner A; Garbe C; Gutzmer R; Hauschild A; Heinzerling L; Livingstone E; Loquai C; Schadendorf D; Terheyden P; Mueller-Brenne T; Kähler KC
Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12901. PubMed ID: 30126009
[TBL] [Abstract][Full Text] [Related]
15. Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4).
Hinz A; Schulte T; Mehnert-Theuerkauf A; Richter D; Sender A; Brock H; Friedrich M; Briest S
Healthcare (Basel); 2024 Feb; 12(4):. PubMed ID: 38391810
[TBL] [Abstract][Full Text] [Related]
16. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity of fear of progression and anxiety disorders in cancer patients.
Dinkel A; Kremsreiter K; Marten-Mittag B; Lahmann C
Gen Hosp Psychiatry; 2014; 36(6):613-9. PubMed ID: 25213227
[TBL] [Abstract][Full Text] [Related]
18. [Cognitive-Behavioral Group Therapy Addressing Fear of Progression in Cancer Out-Patients].
Rudolph B; Wünsch A; Herschbach P; Dinkel A
Psychother Psychosom Med Psychol; 2018 Jan; 68(1):38-43. PubMed ID: 28718864
[TBL] [Abstract][Full Text] [Related]
19. Fear of Progression is Determined by Anxiety and Self-Efficacy but not Disease-Specific Parameters in Patients with Parkinson's Disease: Preliminary Data from a Multicenter Cross-Sectional Study.
Folkerts AK; Haarmann L; Nielsen J; Saliger J; Eschweiler M; Karbe H; Allert N; Vida V; Trenkwalder C; Kruse A; Oelsner H; Ebersbach G; Kalbe E
J Parkinsons Dis; 2022; 12(8):2543-2553. PubMed ID: 36189603
[TBL] [Abstract][Full Text] [Related]
20. Interconnectivity of fear of progression and generalized anxiety - Network analysis among a sample of hematological cancer survivors.
Göbel P; Kuba K; Götze H; Mehnert-Theuerkauf A; Spitzer C; Hartung T; Esser P
Support Care Cancer; 2023 Mar; 31(4):238. PubMed ID: 36973563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
